Cell and Gene Therapy Drug Delivery Devices Market - Global Outlook and Forecast 2023-2027

Report ID: 684260 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Cell and Gene Therapy Drug Delivery Devices Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cell and Gene Therapy Drug Delivery Devices Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Drug Delivery Devices Overall Market Size
    2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size: 2021 VS 2027
    2.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cell and Gene Therapy Drug Delivery Devices Players in Global Market
    3.2 Top Global Cell and Gene Therapy Drug Delivery Devices Companies Ranked by Revenue
    3.3 Global Cell and Gene Therapy Drug Delivery Devices Revenue by Companies
    3.4 Top 3 and Top 5 Cell and Gene Therapy Drug Delivery Devices Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Cell and Gene Therapy Drug Delivery Devices Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Players in Global Market
        3.6.1 List of Global Tier 1 Cell and Gene Therapy Drug Delivery Devices Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Cell and Gene Therapy Drug Delivery Devices Market Size Markets, 2021 & 2027
        4.1.2 Sterile Insulin Syringe
        4.1.3 Pre-Filled Syringe
        4.1.4 Infusion Bags
    4.2 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
        4.2.1 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2021
        4.2.2 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2022-2027
        4.2.3 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cell and Gene Therapy Drug Delivery Devices Market Size, 2021 & 2027
        5.1.2 Luxturna
        5.1.3 Kymriah
        5.1.4 Provenge
        5.1.5 Zolgensma
        5.1.6 Yescarta
        5.1.7 Strimvelis
    5.2 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
        5.2.1 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2021
        5.2.2 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2022-2027
        5.2.3 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Cell and Gene Therapy Drug Delivery Devices Market Size, 2021 & 2027
    6.2 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
        6.2.1 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2021
        6.2.2 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2022-2027
        6.2.3 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2027
        6.3.2 US Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.3.3 Canada Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.3.4 Mexico Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2027
        6.4.2 Germany Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.4.3 France Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.4.4 U.K. Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.4.5 Italy Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.4.6 Russia Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.4.7 Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.4.8 Benelux Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2027
        6.5.2 China Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.5.3 Japan Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.5.4 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.5.5 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.5.6 India Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2027
        6.6.2 Brazil Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.6.3 Argentina Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2027
        6.7.2 Turkey Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.7.3 Israel Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.7.4 Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
        6.7.5 UAE Cell and Gene Therapy Drug Delivery Devices Market Size, 2016-2027
7 Players Profiles
    7.1 Amgen, Inc.
        7.1.1 Amgen, Inc. Corporate Summary
        7.1.2 Amgen, Inc. Business Overview
        7.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.1.5 Amgen, Inc. Key News
    7.2 Bausch and Lomb Incorporated
        7.2.1 Bausch and Lomb Incorporated Corporate Summary
        7.2.2 Bausch and Lomb Incorporated Business Overview
        7.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.2.5 Bausch and Lomb Incorporated Key News
    7.3 Becton, Dickinson and Company
        7.3.1 Becton, Dickinson and Company Corporate Summary
        7.3.2 Becton, Dickinson and Company Business Overview
        7.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.3.5 Becton, Dickinson and Company Key News
    7.4 Bluebird bio, Inc.
        7.4.1 Bluebird bio, Inc. Corporate Summary
        7.4.2 Bluebird bio, Inc. Business Overview
        7.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.4.5 Bluebird bio, Inc. Key News
    7.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
        7.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Corporate Summary
        7.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
        7.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Key News
    7.6 Dendreon Pharmaceuticals LLC.
        7.6.1 Dendreon Pharmaceuticals LLC. Corporate Summary
        7.6.2 Dendreon Pharmaceuticals LLC. Business Overview
        7.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.6.5 Dendreon Pharmaceuticals LLC. Key News
    7.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
        7.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Corporate Summary
        7.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
        7.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.4.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Key News
    7.8 Human Stem Cell Institute
        7.8.1 Human Stem Cell Institute Corporate Summary
        7.8.2 Human Stem Cell Institute Business Overview
        7.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.8.5 Human Stem Cell Institute Key News
    7.9 Kite Pharma, Inc.
        7.9.1 Kite Pharma, Inc. Corporate Summary
        7.9.2 Kite Pharma, Inc. Business Overview
        7.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.9.5 Kite Pharma, Inc. Key News
    7.10 Kolon Tissue Gene, inc.
        7.10.1 Kolon Tissue Gene, inc. Corporate Summary
        7.10.2 Kolon Tissue Gene, inc. Business Overview
        7.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.10.5 Kolon Tissue Gene, inc. Key News
    7.11 Novartis AG
        7.11.1 Novartis AG Corporate Summary
        7.11.2 Novartis AG Business Overview
        7.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.11.5 Novartis AG Key News
    7.12 Orchard Therapeutics plc.
        7.12.1 Orchard Therapeutics plc. Corporate Summary
        7.12.2 Orchard Therapeutics plc. Business Overview
        7.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.12.5 Orchard Therapeutics plc. Key News
    7.13 Pfizer, Inc.
        7.13.1 Pfizer, Inc. Corporate Summary
        7.13.2 Pfizer, Inc. Business Overview
        7.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.13.5 Pfizer, Inc. Key News
    7.14 Renova Therapeutics
        7.14.1 Renova Therapeutics Corporate Summary
        7.14.2 Renova Therapeutics Business Overview
        7.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.14.5 Renova Therapeutics Key News
    7.15 Spark Therapeutics, Inc.
        7.15.1 Spark Therapeutics, Inc. Corporate Summary
        7.15.2 Spark Therapeutics, Inc. Business Overview
        7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.15.5 Spark Therapeutics, Inc. Key News
    7.16 uniQure N.V.
        7.16.1 uniQure N.V. Corporate Summary
        7.16.2 uniQure N.V. Business Overview
        7.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.16.5 uniQure N.V. Key News
    7.17 Vericel Corporation
        7.17.1 Vericel Corporation Corporate Summary
        7.17.2 Vericel Corporation Business Overview
        7.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
        7.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue in Global (2016-2021)
        7.17.5 Vericel Corporation Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Cell and Gene Therapy Drug Delivery Devices Market Opportunities & Trends in Global Market
    Table 2. Cell and Gene Therapy Drug Delivery Devices Market Drivers in Global Market
    Table 3. Cell and Gene Therapy Drug Delivery Devices Market Restraints in Global Market
    Table 4. Key Players of Cell and Gene Therapy Drug Delivery Devices in Global Market
    Table 5. Top Cell and Gene Therapy Drug Delivery Devices Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Cell and Gene Therapy Drug Delivery Devices Product Type
    Table 9. List of Global Tier 1 Cell and Gene Therapy Drug Delivery Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022-2027
    Table 30. Amgen, Inc. Corporate Summary
    Table 31. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 32. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 33. Bausch and Lomb Incorporated Corporate Summary
    Table 34. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 35. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 36. Becton, Dickinson and Company Corporate Summary
    Table 37. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 38. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 39. Bluebird bio, Inc. Corporate Summary
    Table 40. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 41. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 42. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Corporate Summary
    Table 43. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 44. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 45. Dendreon Pharmaceuticals LLC. Corporate Summary
    Table 46. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 47. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 48. Helixmith Co., Ltd (ViroMed Co., Ltd) Corporate Summary
    Table 49. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 50. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 51. Human Stem Cell Institute Corporate Summary
    Table 52. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 53. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 54. Kite Pharma, Inc. Corporate Summary
    Table 55. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 56. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 57. Kolon Tissue Gene, inc. Corporate Summary
    Table 58. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 59. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 60. Novartis AG Corporate Summary
    Table 61. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 62. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 63. Orchard Therapeutics plc. Corporate Summary
    Table 64. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 65. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 66. Pfizer, Inc. Corporate Summary
    Table 67. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 68. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 69. Renova Therapeutics Corporate Summary
    Table 70. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 71. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 72. Spark Therapeutics, Inc. Corporate Summary
    Table 73. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 74. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 75. uniQure N.V. Corporate Summary
    Table 76. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 77. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
    Table 78. Vericel Corporation Corporate Summary
    Table 79. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Offerings
    Table 80. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Cell and Gene Therapy Drug Delivery Devices Segment by Type
    Figure 2. Cell and Gene Therapy Drug Delivery Devices Segment by Application
    Figure 3. Global Cell and Gene Therapy Drug Delivery Devices Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2020
    Figure 8. By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 12. US Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 16. Germany Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 17. France Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 24. China Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 28. India Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 30. Brazil Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2016-2027
    Figure 33. Turkey Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2016-2027
    Figure 37. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 46. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 47. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 48. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 49. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 50. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 51. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 52. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 53. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Cell and Gene Therapy Drug Delivery Devices Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell and Gene Therapy Drug Delivery Devices Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell and Gene Therapy Drug Delivery Devices Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical AI Market

This report contains market size and forecasts of Medical AI in Global, including the following m ... Read More

Lanthanum Market

This report contains market size and forecasts of Lanthanum in global, including the following ma ... Read More